PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Mystic Management Systems, Inc.

Press Release


Receive press releases from Mystic Management Systems, Inc.: By Email RSS Feeds:

Mersana Teams Up with Mystic’s Document Control Software


Mystic Management Systems' ensur Document Control Software identified as Mersana Therapeutic's newest member of their Quality Department.

Norwich, CT, August 27, 2009 --(PR.com)-- Mystic Management Systems’ document control software product ensur was selected by Mersana Therapeutics, Inc. of Cambridge, Massachusetts, for document and version control of their key quality content. Mersana’s ensur deployment will be in conjunction with the introduction of a second lead product candidate.

"Mersana’s progress in the cancer therapeutics division is globally recognized and being partnered with them in their future success is a tremendous opportunity" said Erica Sullivan-Corbett of Mystic Management Systems, Inc.

The deployment of ensur at Mersana will be validated in line with the FDA’s 21CFR Part 11 regulations and will include the installation of the latest 4.0 version of Document Control, Change Control, CAPA, TMS, Quiz Builder, Form Builder, Quality Binder, Bills of Material, Publish, Mail, Reports, Controlled Printing and Watermarking.

About Mersana Therapeutics, Inc.

Named after the Russian goddess of harvest, Mersana’s strategy is to identify promising cancer agents that faltered in development despite evidence of clinical efficacy and to bring them to fruition.

Mersana, a privately held, venture backed company, utilizes its proprietary nanotechnology platform to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties. The key component of Mersana’s platform is Fleximer®, a novel, biodegradable and bio-inert polymer that can be chemically linked to small molecules and biologics. Mersana’s pipeline includes XMT-1001, a Fleximer-camptothecin conjugate which is currently in Phase 1 clinical trials, and several preclinical oncology compounds. Mersana’s investors include Fidelity Biosciences, ProQuest Investments, Rho Ventures, Harris & Harris Group and PureTech Ventures.

About Mystic Management Systems, Inc.

Mystic Management Systems, Inc. is a twenty-five year old leading global provider of quality software solutions, including document control software, product lifecycle management, product and packaging/specification management, as well as corrective and preventative action. Using applications from Mystic Management Systems, companies throughout the world have been improving profits, reducing costs, and producing better quality products since 1983.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to Mystic Management Systems, Inc. are intended to identify such forward-looking statements. MMS undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations.

For companies interested in learning more about MMS products:
Worldwide: (01) 860-887-2900
www.mysticmsi.com
info@mysticmsi.com

###
Contact Information
Mystic Management Systems, Inc.
Erica Sullivan-Corbett
860-887-2900
Contact
www.mysticmsi.com

Click here to view the list of recent Press Releases from Mystic Management Systems, Inc.
Promote Your Business